Latest GSK Stories
LONDON, December 3, 2014 /PRNewswire/ -- Opportunities for Leading Companies Report Details Asthma and COPD therapies - new study showing you
Three years after CDC recommendations, vaccination rates still low; AADE encourages members to focus more on helping to prevent hepatitis B PHILADELPHIA and CHICAGO, Nov.
CARLSBAD, Calif., Nov. 3, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
LONDON, July 23, 2014 /PRNewswire/ -- Global healthcare company GSK reports Q2 results reflecting a business that is facing currency headwinds, increased price competition
Carbapenem Resistance Consortium Includes AstraZeneca, Cepheid, Cubist, and GSK SUNNYVALE, Calif., June 19, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced a new collaboration with
LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- Potential Therapeutic Candidates Now Identified for All Three GSK Collaboration Targets - CAMBRIDGE, Mass., April 22, 2014 /PRNewswire/ -- Epizyme, Inc.
Amid accusations of bribery and scandal, GlaxoSmithKline (GSK), one of the leading drug makers, will stop paying doctors to promote its drugs.
GlaxoSmithKline is expected to seek regulatory approval for a malaria vaccine that recently delivered promising results in a large-scale trial conducted across Africa.
- A transitional zone between two communities containing the characteristic species of each.